Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Scott

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Nano Letters|April 25, 2015
Toward Ferroelectric Control of Monolayer MoS2Ariana Nguyen, Pankaj Sharma, Thomas Scott, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Classification models distinguish functional and trafficking effects of KCNQ1 variants to enhance variant interpretationAna C Chang-Gonzalez, Eric W Bell, Carlos G Vanoye, et al.
Influenza and Other Respiratory Viruses|March 18, 2026
Strain Agnostic Influenza Virus Propagation in a Serum-Free, Suspension-Adapted MDCK Cell LineJessica B Huskey, Michelle L Rock, Pooja V Chaudhary, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 27, 2020
Coronary and Structural Heart Disease Interventions During COVID-19 Pandemic: A Road Map for Clinicians and Health Care Delivery SystemsKishore J Harjai, Shikhar Agarwal, Terry Bauch, et al.
JMIR Research Protocols|August 1, 2025
Developing and Evaluating a Bundled Digital Tool to Improve Complex Care and Self-Management of Patients With Inflammatory Bowel Disease: Protocol for a Hybrid Effectiveness-Implementation StudyKaitlyn Delaney Chappell, Melissa Fox, Thomas Scott Armstrong, et al.
Clinical Therapeutics|June 11, 2004
A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of Avonex in patients with multiple sclerosisJ Theodore Phillips, George Rice, Elliot Frohman, et al.
Nature Biotechnology|November 10, 2017
Revisiting the Warnock ruleJ Benjamin Hurlbut, Insoo Hyun, Aaron D Levine, et al.
Nature Biotechnology|December 9, 2017
Erratum: Revisiting the Warnock ruleJ Benjamin Hurlbut, Insoo Hyun, Aaron D Levine, et al.
Neurology and Therapy|June 24, 2021
Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS StudiesSamuel F Hunter, Rany A Aburashed, Raed Alroughani, et al.
Nature Communications|April 14, 2025
Drugit: crowd-sourcing molecular design of non-peptidic VHL bindersThomas Scott, Christian Alan Paul Smethurst, Yvonne Westermaier, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Nano Letters|April 25, 2015
Toward Ferroelectric Control of Monolayer MoS2Ariana Nguyen, Pankaj Sharma, Thomas Scott, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Classification models distinguish functional and trafficking effects of KCNQ1 variants to enhance variant interpretationAna C Chang-Gonzalez, Eric W Bell, Carlos G Vanoye, et al.
Influenza and Other Respiratory Viruses|March 18, 2026
Strain Agnostic Influenza Virus Propagation in a Serum-Free, Suspension-Adapted MDCK Cell LineJessica B Huskey, Michelle L Rock, Pooja V Chaudhary, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 27, 2020
Coronary and Structural Heart Disease Interventions During COVID-19 Pandemic: A Road Map for Clinicians and Health Care Delivery SystemsKishore J Harjai, Shikhar Agarwal, Terry Bauch, et al.
JMIR Research Protocols|August 1, 2025
Developing and Evaluating a Bundled Digital Tool to Improve Complex Care and Self-Management of Patients With Inflammatory Bowel Disease: Protocol for a Hybrid Effectiveness-Implementation StudyKaitlyn Delaney Chappell, Melissa Fox, Thomas Scott Armstrong, et al.
Clinical Therapeutics|June 11, 2004
A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of Avonex in patients with multiple sclerosisJ Theodore Phillips, George Rice, Elliot Frohman, et al.
Nature Biotechnology|November 10, 2017
Revisiting the Warnock ruleJ Benjamin Hurlbut, Insoo Hyun, Aaron D Levine, et al.
Nature Biotechnology|December 9, 2017
Erratum: Revisiting the Warnock ruleJ Benjamin Hurlbut, Insoo Hyun, Aaron D Levine, et al.
Neurology and Therapy|June 24, 2021
Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS StudiesSamuel F Hunter, Rany A Aburashed, Raed Alroughani, et al.
Nature Communications|April 14, 2025
Drugit: crowd-sourcing molecular design of non-peptidic VHL bindersThomas Scott, Christian Alan Paul Smethurst, Yvonne Westermaier, et al.
Pageof 13